Effects of poly-L-arginine on the permeation of hydrophilic compounds through surface ocular tissues

Biological and Pharmaceutical Bulletin

Volumn 29, Issue 1, 2006, Pages 155-160

  Nemoto, Eiichi ^a   Takahashi, Hirokazu ^a   Kobayashi, Daisuke ^a,b   Ueda, Hideo ^a   Morimoto, Yasunori ^a,b  

^a JOSAI UNIVERSITY   (Japan)

^b Research Institute of TTS Technology   (Japan)

Author keywords

Conjunctiva; Cornea; MTT assay; Permeation enhancer; Poly L arginine

Indexed keywords

FLUORESCEIN ISOTHIOCYANATE DEXTRAN; PENETRATION ENHANCING AGENT; POLYARGININE; PYRIDOXAMINE;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONJUNCTIVA; CONTROLLED STUDY; CORNEA; DRUG DELIVERY SYSTEM; ELECTRIC RESISTANCE; EYE; HYDROPHILICITY; MALE; MOLECULAR WEIGHT; NONHUMAN; PERMEABILITY; RABBIT; SCLERA;

ANIMALS; BUFFERS; CONJUNCTIVA; CORNEA; DEXTRANS; ELECTRIC CONDUCTIVITY; ELECTROPHYSIOLOGY; EYE; FLUORESCEIN-5-ISOTHIOCYANATE; MALE; MOLECULAR WEIGHT; PEPTIDES; PERMEABILITY; POLYLYSINE; PYRIDOXAMINE; RABBITS; SCLERA; TETRAZOLIUM SALTS; THIAZOLES;

EID: 29844448699     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.29.155     Document Type: Article

References (33)

1. "Ophthalmic Drug Delivery Systems," Marcel Dekker, Inc., New York, 2003.
2. Sasaki H., Ichikawa M., Kawakami S., Yamamura K., Nishida K., Nakamura J., J. Pharm. Sci., 85, 940-943 (1996).
3. Ahmed I., Patton T. F., Int. J. Pharm., 38, 9-21 (1987).
4. Yi X., Wang Y., Yu F. S., Invest. Ophthalmol. Vis. Sci., 41, 4093-4100 (2000).
5. Weyrauch K. D., Z. Mikrosk. Anat. Forsch., 97, 573-588 (1983).
6. Jager R. D., Aiello L. P., Patel S. C., Cunningham E. T., Jr., Retina, 24, 676-698 (2004).
7. Sasaki H., Yamamura K., Tei C., Nishida K., Nakamura J., J. Drug Target, 3, 129-135 (1995).
8. Rojanasakul Y., Liaw J., Robinson J. R., Int. J. Pharm., 66, 131-142 (1990).
9. Nishihata T., Tomida H., Frederick G., Rytting J. H., Higuchi T., J. Pharm. Pharmacol., 37, 159-163 (1985).
10. Sasaki H., Yamamura K., Mukai T., Nishida K., Nakamura J., Nakashima M., Ichikawa M., Crit. Rev. Ther. Drug Carrier Syst., 16, 85-146 (1999).
11. Illum L., Farraj N. F., Davis S. S., Pharm. Res., 11, 1186-1189 (1994).
12. Miyamoto M., Natsume H., Satoh I., Ohtake K., Yamaguchi M., Kobayashi D., Sugibayashi K., Morimoto Y., Int. J. Pharm., 226, 127-138 (2001).
13. Yu X. Y., Schofield B. H., Croxton T., Takahashi N., Gabrielson E. W., Spannhake E. W., Am. J. Respir. Cell Mol. Biol., 11, 188-198 (1994).
14. McEwan G. T., Jepson M. A., Hirst B. H., Simmons N. L., Biochem. Biophys. Acta, 1148, 51-60 (1993).
15. Ohtake K., Natsume H., Ueda H., Morimoto Y., J. Control. Release, 82, 263-275 (2002).
16. Natsume H., Iwata S., Ohtake K., Miyamoto M., Yamaguchi M., Hosoya K., Kobayashi D., Sugibayashi K., Morimoto Y., Int. J. Pharm., 185, 1-12 (1999).
17. Bisp M. R., Bor M. V., Heinsvig E. M., Kall M. A., Nexo E., Anal. Biochem., 305, 82-89 (2002).
18. Horibe Y., Hosoya K., Kim K. J., Ogiso T., Lee V. H., Pharm. Res., 14, 1246-1251 (1997).
19. Hamalainen K. M., Kananen K., Auriola S., Kontturi K., Urtti A., Invest. Ophthalmol. Vis. Sci., 38, 627-634 (1997).
20. Sasaki H., Igarashi Y., Nagano T., Yamamura K., Nishida K., Nakamura J., J. Pharm. Pharmacol., 47, 17-21 (1995).
21. Ohtake K., Maeno T., Ueda H., Natsume H., Morimoto Y., Pharm. Res., 20, 153-160 (2003).
22. Schipper N. G., Olsson S., Hoogstraate J. A., deBoer A. G., Varum K. M., Artursson P., Pharm. Res., 14, 923-929 (1997).
23. Kotze A. F., Luessen H. L., de Leeuw B. J., de Boer B. G., Verhoef J. C., Junginger H. E., Pharm. Res., 14, 1197-1202 (1997).
24. Tsukita S., Furuse M., Itoh M., Nat. Rev. Mol. Cell Biol., 2, 285-293 (2001).
25. Gonzalez-Mariscal L., Betanzos A., Nava P., Jaramillo B. E., Prog. Biophys. Mol. Biol., 81, 1-44 (2003).
26. Ohtake K., Maeno T., Ueda H., Ogihara M., Natsume H., Morimoto Y., Pharm. Res., 20, 1838-1845 (2003).
27. Peixoto E. B., Collares-Buzato C. B., Cell Struct. Funct., 29, 165-178 (2005).
28. Maurice D. M., Invest. Ophtalmol., 6, 464-477 (1967).
29. Westergren I., Johansson B. B., Acta Physiol. Scand., 149, 99-104 (1993).
30. Lee M., Nah J. W., Kwon Y., Koh J. J., Ko K. S., Kim S. W., Pharm. Res., 18, 427-431 (2001).
31. Huang A. J., Tseng S. C., Kenyon K. R., Invest. Ophthalmol. Vis. Sci., 30, 684-689 (1989).
32. Said H. M., Ortiz A., Ma T. Y., Am. J. Physiol. Cell Physiol., 285, C1219-C1225 (2003).
33. Papa V., Leonardi A., Getuli C., Pacelli V., Russo P., Milazzo G., J. Ocul. Pharmacol. Ther., 19, 535-545 (2003).